» Articles » PMID: 36760719

Propofol-mediated Circ_0000735 Downregulation Restrains Tumor Growth by Decreasing Integrin-β1 Expression in Non-small Cell Lung Cancer

Overview
Journal Open Med (Wars)
Specialty General Medicine
Date 2023 Feb 10
PMID 36760719
Authors
Affiliations
Soon will be listed here.
Abstract

Propofol, an intravenous anesthetic agent, exerts an anti-tumor peculiarity in multifarious tumors. Circular RNA hsa_circ_0000735 (circ_0000735) is involved in non-small cell lung cancer (NSCLC) progression. The purpose of this study is to investigate whether propofol can curb NSCLC progression via regulating circ_0000735 expression. Cell viability, proliferation, apoptosis, and invasion were detected using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, 5-ethynyl-2'-deoxyuridine, flow cytometry, and transwell assays. Evaluation of protein levels was performed using western blotting or immunohistochemistry. Detection of circ_0000735 in tissue samples and cells was carried out using a real-time quantitative polymerase chain reaction. The molecular mechanisms associated with circ_0000735 were predicted by bioinformatics analysis and verified by dual-luciferase reporter assays. The relationship between propofol and circ_0000735 was verified by xenograft models. The results showed that circ_0000735 was overexpressed in NSCLC samples and cells. Propofol treatment overtly decreased circ_0000735 expression in NSCLC cells and repressed NSCLC cell viability, proliferation, invasion, and facilitated NSCLC cell apoptosis, but these effects mediated by propofol were counteracted by circ_0000735 overexpression. Circ_0000735 functioned as a miR-153-3p sponge and regulated integrin-β1 (ITGB1) expression via adsorbing miR-153-3p. ITGB1 overexpression reversed circ_0000735 silencing-mediated effects on NSCLC cell viability, proliferation, invasion, and apoptosis. In conclusion, propofol restrained NSCLC growth by downregulating circ_0000735, which functioned as a miR-153-3p sponge and regulated ITGB1 expression via adsorbing miR-153-3p. This study provides evidence to support that propofol curbs NSCLC progression by regulating circRNA expression.

References
1.
Huang W, Xu X, Liu M, Cui W, Peng G . Downregulation of Hsa_circ_0000735 Inhibits the Proliferation, Migration, Invasion, and Glycolysis in Non-small-cell Lung Cancer by Targeting miR-940/BMPER Axis. Onco Targets Ther. 2020; 13:8427-8439. PMC: 7457839. DOI: 10.2147/OTT.S253474. View

2.
Jiang S, Liu Y, Huang L, Zhang F, Kang R . Effects of propofol on cancer development and chemotherapy: Potential mechanisms. Eur J Pharmacol. 2018; 831:46-51. DOI: 10.1016/j.ejphar.2018.04.009. View

3.
Ma H, Tian T, Liu X, Xia M, Chen C, Mai L . Upregulated circ_0005576 facilitates cervical cancer progression via the miR-153/KIF20A axis. Biomed Pharmacother. 2019; 118:109311. DOI: 10.1016/j.biopha.2019.109311. View

4.
Li Y, Sun C, Tan Y, Zhang H, Li Y, Zou H . ITGB1 enhances the Radioresistance of human Non-small Cell Lung Cancer Cells by modulating the DNA damage response and YAP1-induced Epithelial-mesenchymal Transition. Int J Biol Sci. 2021; 17(2):635-650. PMC: 7893583. DOI: 10.7150/ijbs.52319. View

5.
Lei B, Tian Z, Fan W, Ni B . Circular RNA: a novel biomarker and therapeutic target for human cancers. Int J Med Sci. 2019; 16(2):292-301. PMC: 6367529. DOI: 10.7150/ijms.28047. View